Atypical inflammatory demyelinating syndromes of the CNS

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders

Wingerchuk, D. M., Banwell, B., Bennett, J. L., Cabre, P., Carroll, W., Chitnis, T., de Seze, J., Fujihara, K., Greenberg, B., Jacob, A., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001729 · Cited by 4,649 · see citing works

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

Lennon, V. A., Wingerchuk, D. M., Kryzer, T. J., Pittock, S. J., Lucchinetti, C. F., Fujihara, K., Nakashima, I., & Weinshenker, B. G. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17551-x · Cited by 3,239 · see citing works

Revised diagnostic criteria for neuromyelitis optica

Wingerchuk, D. M., Lennon, V. A., Pittock, S. J., Lucchinetti, C. F., & Weinshenker, B. G. (2006) · Neurology · doi:10.1212/01.wnl.0000216139.44259.74 · Cited by 2,568 · see citing works

The spectrum of neuromyelitis optica

Wingerchuk, D. M., Lennon, V. A., Lucchinetti, C. F., Pittock, S. J., & Weinshenker, B. G. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70216-8 · Cited by 2,182 · see citing works

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica.

Lucchinetti, C., Mandler, R., McGavern, D., Brück, W., Gleich, G., Ransohoff, R., Trebst, C., Weinshenker, B., Wingerchuk, D., Parisi, J., et al. (2002) · Brain : a journal of neurology · doi:10.1093/brain/awf151 · Cited by 1,228 · see citing works

International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions

Krupp, L. B., Tardieu, M., Amato, M. P., Banwell, B., Chitnis, T., Dale, R. C., Ghezzi, A., Hintzen, R., Kornberg, A., Pohl, D., et al. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513484547 · Cited by 1,130 · see citing works

MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines

Filippi, M., Rocca, M. A., Ciccarelli, O., De Stefano, N., Evangelou, N., Kappos, L., Rovira, A., Sastre-Garriga, J., Tintorè, M., Frederiksen, J. L., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00393-2 · Cited by 880 · see citing works

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders

Sato, D. K., Callegaro, D., Lana-Peixoto, M. A., Waters, P. J., Jorge, F. M. D. H., Takahashi, T., Nakashima, I., Apostolos-Pereira, S. L., Talim, N., Simm, R. F., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000101 · Cited by 850 · see citing works

Consensus definitions proposed for pediatric multiple sclerosis and related disorders

Krupp, L., Banwell, B., & Tenembaum, S. N. (2007) · Neurology · doi:10.1212/01.wnl.0000259422.44235.a8 · Cited by 754 · see citing works

Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis

Roemer, S. F., Parisi, J. E., Lennon, V. A., Benarroch, E. E., Lassmann, H., Brück, W., Mandler, R. N., Weinshenker, B. G., Pittock, S. J., Wingerchuk, D. M., et al. (2007) · Brain · doi:10.1093/brain/awl371 · Cited by 716 · see citing works

Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children

Dale, R. C. (2000) · Brain · doi:10.1093/brain/123.12.2407 · Cited by 703 · see citing works

Neuromyelitis Optica Brain Lesions Localized at Sites of High Aquaporin 4 Expression

Pittock, S. J., Weinshenker, B. G., Lucchinetti, C. F., Wingerchuk, D. M., Corboy, J. R., & Lennon, V. A. (2006) · Archives of Neurology · doi:10.1001/archneur.63.7.964 · Cited by 699 · see citing works

MRI characteristics of neuromyelitis optica spectrum disorder: An international update

Kim, H. J., Paul, F., Lana-Peixoto, M. A., Tenembaum, S., Asgari, N., Palace, J., Klawiter, E. C., Sato, D. K., de Seze, J., Wuerfel, J., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001367 · Cited by 664 · see citing works

Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis

Misu, T., Fujihara, K., Kakita, A., Konno, H., Nakamura, M., Watanabe, S., Takahashi, T., Nakashima, I., Takahashi, H., & Itoyama, Y. (2007) · Brain · doi:10.1093/brain/awm047 · Cited by 613 · see citing works

Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies: A Comparative Study

Kitley, J., Waters, P., Woodhall, M., Leite, M. I., Murchison, A., George, J., Küker, W., Chandratre, S., Vincent, A., & Palace, J. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.5857 · Cited by 597 · see citing works

Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)

Neuromyelitis Optica Study Group (NEMOS), Trebst, C., Jarius, S., Berthele, A., Paul, F., Schippling, S., Wildemann, B., Borisow, N., Kleiter, I., Aktas, O., et al. (2014) · Journal of Neurology · doi:10.1007/s00415-013-7169-7 · Cited by 595 · see citing works

Aquaporin 4 and neuromyelitis optica

Papadopoulos, M., & Verkman, A. S. (2012) · Lancet Neurology · doi:10.1016/s1474-4422(12)70133-3 · Cited by 574 · see citing works

Overlapping demyelinating syndromes and anti–N‐methyl‐D‐aspartate receptor encephalitis

Titulaer, M. J., Höftberger, R., Iizuka, T., Leypoldt, F., McCracken, L., Cellucci, T., Benson, L. A., Shu, H., Irioka, T., Hirano, M., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24117 · Cited by 518 · see citing works

Acute disseminated encephalomyelitis: A follow-up study of 40 adult patients

Schwarz, S., Mohr, A., Knauth, M., Wildemann, B., & Storch–Hagenlocher, B. (2001) · Neurology · doi:10.1212/wnl.56.10.1313 · Cited by 511 · see citing works

Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis

Lucchinetti, C. F., Gavrilova, R. H., Metz, I., Parisi, J. E., Scheithauer, B. W., Weigand, S., Thomsen, K., Mandrekar, J., Altintas, A., Erickson, B. J., et al. (2008) · Brain · doi:10.1093/brain/awn098 · Cited by 493 · see citing works

Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype

Kitley, J., Woodhall, M., Waters, P., Leite, M. I., Devenney, E., Craig, J., Palace, J., & Vincent, A. (2012) · Neurology · doi:10.1212/wnl.0b013e31826aac4e · Cited by 445 · see citing works

Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses

Kleiter, I., Gahlen, A., Borisow, N., Fischer, K., Wernecke, K., Wegner, B., Hellwig, K., Pache, F. C., Ruprecht, K., Havla, J. B., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24554 · Cited by 433 · see citing works

The Pathology of an Autoimmune Astrocytopathy: Lessons Learned from Neuromyelitis Optica

Lucchinetti, C. F., Guo, Y. X., Popescu, B. F. G., Fujihara, K., Itoyama, Y., & Misu, T. (2013) · Brain Pathology · doi:10.1111/bpa.12099 · Cited by 415 · see citing works

Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study

Pittock, S. J., Lennon, V. A., McKeon, A. B., Mandrekar, J. N., Weinshenker, B. G., Lucchinetti, C. F., O’Toole, O., & Wingerchuk, D. M. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70076-0 · Cited by 392 · see citing works

MOG cell-based assay detects non-MS patients with inflammatory neurologic disease

Waters, P. J., Woodhall, M. R., O’Connor, K. C., Reindl, M., Lang, B., Sato, D. K., Juryńczyk, M., Tackley, G., Rocha, J., Takahashi, T., et al. (2015) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000089 · Cited by 392 · see citing works

Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis

Ramanathan, S., Prelog, K., Barnes, E. H., Tantsis, E. M., Reddel, S. W., Henderson, A. P., Vucic, S., Gorman, M. P., Benson, L. A., Alper, G., et al. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458515593406 · Cited by 384 · see citing works

The spectrum of MOG autoantibody-associated demyelinating diseases

Reindl, M., Pauli, F. D., Rostasy, K. M., & Berger, T. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.118 · Cited by 373 · see citing works

Acute Disseminated Encephalomyelitis

Menge, T., Hemmer, B., Nessler, S., Wiendl, H., Neuhaus, O., Hartung, H.-P., Kieseier, B. C., & Stüve, O. (2005) · Archives of Neurology · doi:10.1001/archneur.62.11.1673 · Cited by 367 · see citing works

Demographic and clinical features of neuromyelitis optica: A review

Pandit, L., Asgari, N., Apiwattanakul, M., Palace, J., Paul, F., Leite, M., Kleiter, I., Chitnis, T., & the GJCF International Clinical Consortium & Biorepository for Neuromyelitis Optica (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515572406 · Cited by 341 · see citing works

Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes

Hinson, S. R., Romero, M., Popescu, B. F. G., Lucchinetti, C., Fryer, J., Wolburg, H., Fallier-Becker, P., Noell, S., & Lennon, V. (2011) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1109980108 · Cited by 321 · see citing works

Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein

Baumann, M., Sahin, K., Lechner, C., Hennes, E. M., Schanda, K., Mader, S., Karenfort, M., Selch, C., Häusler, M., Eisenkölbl, A., et al. (2014) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-308346 · Cited by 313 · see citing works

Comparison of Relapse and Treatment Failure Rates Among Patients With Neuromyelitis Optica

Mealy, M. A., Wingerchuk, D. M., Palace, J. A., Greenberg, B. M., & Levy, M. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.5699 · Cited by 303 · see citing works

Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis

Pröbstel, A., Dornmair, K., Bittner, R., Sperl, P., Jenne, D. E., de Magalhaes, S. L. B., Villalobos, A., Breithaupt, C., Weissert, R., Jacob, U., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e318228c0b1 · Cited by 302 · see citing works

Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease

Höftberger, R., Sepúlveda, M., Armangué, T., Blanco, Y., Rostasy, K. M., Cobo‐Calvo, Á., Olascoaga, J., Ramió‐Torrentà, L., Reindl, M., Benito‐León, J., et al. (2014) · Multiple Sclerosis Journal · doi:10.1177/1352458514555785 · Cited by 285 · see citing works

Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder?

Zamvil, S. S., & Slavin, A. (2015) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000062 · Cited by 276 · see citing works

Acute multiple sclerosis (marburg type) is associated with developmentally immature myelin basic protein

Wood, D. D., Moscarello, M. A., Bilbao, J. M., & O'Connors, P. (1996) · Annals of Neurology · doi:10.1002/ana.410400106 · Cited by 266 · see citing works

Treatment of acute relapses in neuromyelitis optica: Steroids alone versus steroids plus plasma exchange

Abboud, H., Petrak, A., Mealy, M. A., Sasidharan, S., Siddique, L., & Levy, M. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515581438 · Cited by 245 · see citing works

Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum Disorder

Ringelstein, M., Ayzenberg, I., Harmel, J., Lauenstein, A.-S., Lensch, E., Stögbauer, F., Hellwig, K., Ellrichmann, G., Stettner, M., Chan, A., et al. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.0533 · Cited by 242 · see citing works

Tissue preconditioning may explain concentric lesions in Baló's type of multiple sclerosis

Stadelmann, C., Ludwin, S. K., Tabira, T., Guseo, A., Lucchinetti, C. F., Leel-Ôssy, L., Ordinario, A. T., Brück, W., & Lassmann, H. (2005) · Brain · doi:10.1093/brain/awh457 · Cited by 233 · see citing works

Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis

Ramanathan, S., Reddel, S., Henderson, A. P. D., Parratt, J. D. E., Barnett, M. H., Gatt, P. N., Merheb, V., Kumaran, R.-Y. A., Pathmanandavel, K., Sinmaz, N., et al. (2014) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000040 · Cited by 232 · see citing works

Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children

Hacohen, Y., Absoud, M., Deiva, K., Hemingway, C., Nytrova, P., Woodhall, M., Palace, J., Wassmer, E., Tardieu, M., Vincent, A., et al. (2015) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000081 · Cited by 230 · see citing works

Pathology of demyelinating diseases.

Popescu, B. F. G., & Lucchinetti, C. (2012) · Annual Review of Pathology · doi:10.1146/annurev-pathol-011811-132443 · Cited by 228 · see citing works

Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution

Matthews, L., Marasco, R., Jenkinson, M., Küker, W., Luppe, S., Leite, M. I., Giorgio, A., De Stefano, N., Robertson, N., Johansen-Berg, H., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e3182887957 · Cited by 225 · see citing works

The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease

Wingerchuk, D. M., & Weinshenker, B. G. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511431077 · Cited by 224 · see citing works

Treatment Outcomes With Rituximab in 100 Patients With Neuromyelitis Optica

Kim, S., Jeong, I. H., Hyun, J., Joung, A., Jo, H.-J., Hwang, S., Yun, S., Joo, J., & Kim, H. J. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.1276 · Cited by 209 · see citing works

Myasthenia gravis and neuromyelitis optica spectrum disorder

Leite, M. I., Coutinho, E., Lana–Peixoto, M. A., Apóstolos‐Pereira, S. L., Waters, P. J., Sato, D. K., Melamud, L., Marta, M., Graham, A., Spillane, J. E., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31825644ff · Cited by 204 · see citing works

Beneficial Plasma Exchange Response in Central Nervous System Inflammatory Demyelination

Magaña, S. M. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.34 · Cited by 200 · see citing works

Perivenous demyelination: association with clinically defined acute disseminated encephalomyelitis and comparison with pathologically confirmed multiple sclerosis

Young, N. P., Weinshenker, B. G., Parisi, J. E., Scheithauer, B. W., Giannini, C., Roemer, S. F., Thomsen, K. M., Mandrekar, J. N., Erickson, B. J., & Lucchinetti, C. F. (2010) · Brain · doi:10.1093/brain/awp321 · Cited by 186 · see citing works

Zur Kenntnis der sogenannten diffusen Sklerose. (Über Encephalitis periaxialis diffusa.)

Schilder, P. (1912) · Zeitschrift für die gesamte Neurologie und Psychiatrie · doi:10.1007/bf02901445 · Cited by 184 · see citing works

Anti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort

Ketelslegers, I. A., van Pelt, D., Bryde, S., Neuteboom, R. F., Catsman‐Berrevoets, C. E., Hamann, D., & Hintzen, R. Q. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458514566666 · Cited by 180 · see citing works

The search for the target antigens of multiple sclerosis, part 2: CD8+ T cells, B cells, and antibodies in the focus of reverse-translational research

Hohlfeld, R., Dornmair, K., Meinl, E., & Wekerle, H. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00313-0 · Cited by 179 · see citing works

Histopathology and clinical course of MOG-antibody-associated encephalomyelitis

Spadaro, M., Gerdes, L. A., Mayer, M. C., Ertl-Wagner, B. B., Laurent, S. A., Krumbholz, M., Breithaupt, C., Högen, T., Straube, A. M., Giese, A., et al. (2015) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.164 · Cited by 176 · see citing works

Neuromyelitis optica pathogenesis and aquaporin 4

Graber, D. J., Levy, M., Kerr, D. A., & Wade, W. F. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-22 · Cited by 170 · see citing works

Tumefactive demyelination: an approach to diagnosis and management

Hardy, T. A., & Chataway, J. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304498 · Cited by 164 · see citing works

Distinguishing Tumefactive Demyelinating Lesions from Glioma or Central Nervous System Lymphoma: Added Value of Unenhanced CT Compared with Conventional Contrast-enhanced MR Imaging

Kim, D. S., Na, D. G., Kim, K. H., Kim, J., Kim, E., Yun, B. L., & Chang, K. (2009) · Radiology · doi:10.1148/radiol.2512072071 · Cited by 159 · see citing works

The pathological spectrum of CNS inflammatory demyelinating diseases

Hu, W., & Lucchinetti, C. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0178-z · Cited by 157 · see citing works

Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica

Rostasy, K. M., Mader, S., Hennes, E. M., Schanda, K., Gredler, V., Guenther, A., Blaschek, A., Korenke, C., Pritsch, M., Pohl, D., et al. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458512470310 · Cited by 154 · see citing works

Acute disseminated encephalomyelitis followed by recurrent or monophasic optic neuritis in pediatric patients

Huppke, P., Rostasy, K. M., Karenfort, M., Huppke, B., Seidl, R., Leiz, S., Reindl, M., & Gärtner, J. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458512466317 · Cited by 151 · see citing works

Clinical and radiological characteristics of tumefactive demyelinating lesions: follow-up study

Altıntaş, A., Petek, B., Isik, N., Terzi, M., Bölükbaşı, F. H., Tavşanlı, M. E., Saip, S., Boz, C., Aydın, T., Arici-Duz, O., et al. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458512438237 · Cited by 151 · see citing works

The MRI Appearance of Tumefactive Demyelinating Lesions

Given, C. A., Stevens, B. S., & Lee, C. (2004) · American Journal of Roentgenology · doi:10.2214/ajr.182.1.1820195 · Cited by 144 · see citing works

Metabolite Findings in Tumefactive Demyelinating Lesions Utilizing Short Echo Time Proton Magnetic Resonance Spectroscopy

Kalis, M., Bowen, B. C., & Quencer, R. M. (2007) · American Journal of Neuroradiology · doi:10.3174/ajnr.a0669 · Cited by 142 · see citing works

Differentiating neuromyelitis optica from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging

Pekçevik, Y., Mitchell, C. H., Mealy, M. A., Orman, G., Lee, I. H., Newsome, S. D., Thompson, C. B., Pardo, C. A., Calabresi, P. A., Levy, M., et al. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515591069 · Cited by 140 · see citing works

Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain

Saadoun, S., Waters, P. J., Owens, G. P., Bennett, J. L., Vincent, A. C., & Papadopoulos, M. C. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-35 · Cited by 137 · see citing works

Neuromyelitis optica: a demyelinating disease characterized by acute destruction and regeneration of perivascular astrocytes

Parratt, J. D. E., & Prineas, J. W. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458510382324 · Cited by 132 · see citing works

“Bright spotty lesions” on spinal magnetic resonance imaging differentiate neuromyelitis optica from multiple sclerosis

Yonezu, T., Ito, S., Mori, M., Ogawa, Y., Makino, T., Uzawa, A., & Kuwabara, S. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513495581 · Cited by 129 · see citing works

Baló's concentric sclerosis

Hardy, T. A., & Miller, D. H. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70052-3 · Cited by 123 · see citing works

Massive astrocyte destruction in neuromyelitis optica despite natalizumab therapy

Barnett, M. H., Prineas, J. W., Buckland, M., Parratt, J., & Pollard, J. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511421185 · Cited by 122 · see citing works

Acute demyelinating disease. Classification and non-invasive diagnosis

Poser, S., Lüer, W., Bruhn, H., Frahm, J., Brück, Y., & Felgenhauer, K. (1992) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1992.tb05490.x · Cited by 119 · see citing works

Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease

Lechner, C., Baumann, M., Hennes, E.-M., Schanda, K., Marquard, K., Karenfort, M., Leiz, S., Pohl, D., Venkateswaran, S., Pritsch, M., et al. (2015) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-311743 · Cited by 117 · see citing works

Prediction of Neuromyelitis Optica Attack Severity by Quantitation of Complement-Mediated Injury to Aquaporin-4–Expressing Cells

Hinson, S. R., McKeon, A. B., Fryer, J. P., Apiwattanakul, M., Lennon, V. A., & Pittock, S. J. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.188 · Cited by 117 · see citing works

Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in ‘pattern II multiple sclerosis’ and brain biopsy findings in a MOG-IgG-positive case

Jarius, S., Metz, I., König, F. B., Ruprecht, K., Reindl, M., Paul, F., Brück, W., & Wildemann, B. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458515622986 · Cited by 116 · see citing works

Schilder's Myelinoclastic Diffuse Sclerosis

Poser, C. M., Goutières, F., Carpentier, M., & Alcardi, J. (1986) · PEDIATRICS · doi:10.1542/peds.77.1.107 · Cited by 112 · see citing works

Immune-mediated CNS diseases: A review on nosological classification and clinical features

Zettl, U. K., Stüve, O., & Patejdl, R. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.05.008 · Cited by 101 · see citing works

Primary Central Nervous System Lymphoma: From Clinical Presentation to Diagnosis

Herrlinger, U., Schabet, M., Bitzer, M., Petersen, D., & Krauseneck, P. (1999) · Journal of Neuro-Oncology · doi:10.1023/a:1006298201101 · Cited by 99 · see citing works

MRI characteristics of atypical idiopathic inflammatory demyelinating lesions of the brain: A review of reported findings

for the MAGNIMS network, Seewann, A., Enzinger, C., Filippi, M., Barkhof, F., Rovira, A., Gass, A., Miller, D., Montalban, X., Thompson, A., et al. (2008) · Journal of Neurology · doi:10.1007/s00415-007-0754-x · Cited by 98 · see citing works

Clinical and diagnostic aspects of multiple sclerosis and acute monophasic encephalomyelitis in pediatric patients: a single centre prospective study

Atzori, M., Battistella, P. A., de Perini, P., Calabrese, M., Fontanin, M., Laverda, A., Suppiej, A., Drigo, P., Grossi, P., Rinaldi, L., et al. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458508098562 · Cited by 91 · see citing works

Acute disseminated encephalomyelitis: current controversies in diagnosis and outcome

Koelman, D. L. H., & Mateen, F. J. (2015) · Journal of Neurology · doi:10.1007/s00415-015-7694-7 · Cited by 89 · see citing works

The Magnetic Resonance Imaging Appearance of Monophasic Acute Disseminated Encephalomyelitis

Marin, S. E., & Callen, D. J. A. (2013) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2012.12.005 · Cited by 84 · see citing works

Zur Frage der Encephalitis periaxialis diffusa (sogenannte diffuse Sklerose)

Schilder, P. (1913) · Zeitschrift für die gesamte Neurologie und Psychiatrie · doi:10.1007/bf02895263 · Cited by 84 · see citing works

Atypical idiopathic inflammatory demyelinating lesions: prognostic implications and relation to multiple sclerosis

Wallner-Blazek, M., Rovira, A., Fillipp, M., Rocca, M. A., Miller, D. H., Schmierer, K., Frederiksen, J., Gass, A., Gama, H., Tilbery, C. P., et al. (2013) · Journal of Neurology · doi:10.1007/s00415-013-6918-y · Cited by 84 · see citing works

Fulminant demyelinating encephalomyelitis

Pauli, F. D., Höftberger, R., Reindl, M., Beer, R., Rhomberg, P., Schanda, K., Sato, D. K., Fujihara, K., Lassmann, H., Schmutzhard, E., et al. (2015) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000175 · Cited by 83 · see citing works

Malignant monophasic multiple sclerosis or “Marburg's disease"

Mendez, M. F., & Pogacar, S. (1988) · Neurology · doi:10.1212/wnl.38.7.1153 · Cited by 83 · see citing works

Characteristic Neuroimaging in Patients with Tumefactive Demyelinating Lesions Exceeding 30 mm

Kiriyama, T., Kataoka, H., Taoka, T., Tonomura, Y., Terashima, M., Morikawa, M., Tanizawa, E., Kawahara, M., Furiya, Y., Sugie, K., et al. (2010) · Journal of Neuroimaging · doi:10.1111/j.1552-6569.2010.00502.x · Cited by 79 · see citing works

Die Encephalitis periaxialis diffusa

Schilder, P. (1924) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf01813381 · Cited by 79 · see citing works

Tumefactive MS lesions under fingolimod

Pilz, G., Harrer, A., Wipfler, P., Oppermann, K., Sellner, J., Fazekas, F., Trinka, E., & Kraus, J. (2013) · Neurology · doi:10.1212/01.wnl.0000435293.34351.11 · Cited by 78 · see citing works

The corpus callosum in the diagnosis of multiple sclerosis and other CNS demyelinating and inflammatory diseases

Garg, N., Reddel, S. W., Miller, D. H., Chataway, J., Riminton, D. S., Barnett, Y., Masters, L., Barnett, M. H., & Hardy, T. A. (2015) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-309649 · Cited by 76 · see citing works

Diffusion-weighted imaging characteristics of biopsy-proven demyelinating brain lesions

Zeid, N. E. A., Pirko, I., Erickson, B. J., Weigand, S. D., Thomsen, K. M., Scheithauer, B. W., Parisi, J. E., Giannini, C., Linbo, L., & Lucchinetti, C. F. (2012) · Neurology · doi:10.1212/wnl.0b013e3182574f66 · Cited by 71 · see citing works

The Origins of Concentric Demyelination: Self-Organization in the Human Brain

Khonsari, R. H., & Calvez, V. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000150 · Cited by 68 · see citing works

Conventional and Advanced Imaging in Neuromyelitis Optica

Barnett, Y., Sutton, I., Ghadiri, M., Masters, L. T., Zivadinov, R., & Barnett, M. H. (2013) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3592 · Cited by 66 · see citing works

Neuromyelitis optica and astrocytic damage in its pathogenesis

Fujihara, K. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.02.018 · Cited by 66 · see citing works

Metabolite Findings in Tumefactive Demyelinating Lesions Utilizing Short Echo Time Proton Magnetic Resonance Spectroscopy

Osborn, A. G. (2007) · Yearbook of Diagnostic Radiology · doi:10.1016/s0098-1672(08)70230-3 · Cited by 66 · see citing works

Fluorodeoxyglucose positron emission tomography (FDG-PET) is useful in the diagnosis of neurosarcoidosis

Bolat, S., Berding, G., Dengler, R., Stangel, M., & Trebst, C. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.08.060 · Cited by 64 · see citing works

Treatment of Marburg Variant Multiple Sclerosis with Mitoxantrone

Jeffery, D., Lefkowitz, D. S., & Crittenden, J. P. (2004) · Journal of Neuroimaging · doi:10.1111/j.1552-6569.2004.tb00217.x · Cited by 63 · see citing works

Utility of Proton MR Spectroscopy for Differentiating Typical and Atypical Primary Central Nervous System Lymphomas from Tumefactive Demyelinating Lesions

Lu, S., Kim, S. J., Kim, H. S., Choi, C. G., Lim, Y., Kim, E. J., Kim, D. Y., & Cho, S. H. (2013) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3677 · Cited by 63 · see citing works

Massive CNS monocytic infiltration at autopsy in an alemtuzumab-treated patient with NMO

Gelfand, J. M., Cotter, J. A., Klingman, J. G., Huang, E. J., & Cree, B. (2014) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000034 · Cited by 60 · see citing works

Therapeutic Approach to the Management of Pediatric Demyelinating Disease: Multiple Sclerosis and Acute Disseminated Encephalomyelitis

Brenton, J. N., & Banwell, B. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0396-0 · Cited by 59 · see citing works

Bright spotty lesions on the spinal cord: an additional MRI indicator of neuromyelitis optica spectrum disorder?

Hyun, J., Kim, S., Jeong, I. H., Lee, S. H., & Kim, H. J. (2015) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-309761 · Cited by 58 · see citing works

Baló's disease showing benign clinical course and co-existence with multiple sclerosis-like lesions in Chinese

Wang, C., Kun-nan, Z., Wu, X., Huang, G., Xie, X., Qu, X.-H., & Xiong, Y. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458507084036 · Cited by 58 · see citing works

Exploring the overlap between multiple sclerosis, tumefactive demyelination and Baló’s concentric sclerosis

Hardy, T. A., Tobin, W. O., & Lucchinetti, C. F. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458516641776 · Cited by 58 · see citing works

Diagnostic utility of aquaporin-4 in the analysis of active demyelinating lesions

Popescu, B. F. G., Guo, Y. X., Jentoft, M. E., Parisi, J. E., Lennon, V. A., Pittock, S. J., Weinshenker, B. G., Wingerchuk, D. M., Giannini, C., Metz, I., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000001126 · Cited by 53 · see citing works

A Benign Form of Neuromyelitis Optica

Collongues, N. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.127 · Cited by 53 · see citing works

Tumefactive demyelinating lesions as a first clinical event: Clinical, imaging, and follow-up observations

Jeong, I. H., Kim, S., Hyun, J., Joung, A., Cho, H., & Kim, H. J. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2015.08.034 · Cited by 52 · see citing works

Astrocytopathy in Baló’s disease

Kira, J. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511400475 · Cited by 47 · see citing works

Marburg's Variant of Multiple Sclerosis Correlates with a Less Compact Structure of Myelin Basic Protein

Beniac, D. R., Wood, D. D., Palaniyar, N., Ottensmeyer, F. P., Moscarello, M. A., & Harauz, G. (1999) · Molecular Cell Biology Research Communications · doi:10.1006/mcbr.1999.0111 · Cited by 46 · see citing works

Persistence of Immunopathological and Radiological Traits in Multiple Sclerosis

König, F. B., Wildemann, B., Nessler, S., Zhou, D., Hemmer, B., Metz, I., Hartung, H., Kieseier, B. C., & Brück, W. (2008) · Archives of Neurology · doi:10.1001/archneur.65.11.1527 · Cited by 45 · see citing works

High dose cyclophosphamide treatment in Marburg variant multiple sclerosis

Nozaki, K., & Abou-Fayssal, N. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.05.022 · Cited by 45 · see citing works

Metabolic assessment of monofocal acute inflammatory demyelination using MR spectroscopy and 11C-methionine-, 11C-choline-, and 18F-fluorodeoxyglucose-PET

Takenaka, S., Shinoda, J., Asano, Y., Aki, T., Miwa, K., Ito, T., Yokoyama, K., & Iwama, T. (2011) · Brain Tumor Pathology · doi:10.1007/s10014-011-0027-3 · Cited by 45 · see citing works

Anti-aquaporin-4 autoantibodies in systemic lupus erythematosus persist for years and induce astrocytic cytotoxicity but not CNS disease

Alexopoulos, H., Kampylafka, E. I., Fouka, P., Tatouli, I. P., Akrivou, S., Politis, P. K., Moutsopoulos, H. Μ., Tzioufas, A. G., & Dalakas, M. C. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.10.007 · Cited by 42 · see citing works

Evolution and long term outcome in patients presenting with large demyelinating lesions as their first clinical event

Wattamwar, P. R., Baheti, N., Kesavadas, C., Nair, M., & Radhakrishnan, A. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.06.030 · Cited by 40 · see citing works

Neuromyelitis optica: a positive appraisal of seronegative cases

Bernard‐Valnet, R., Liblau, R., Vukusic, S., & Marignier, R. (2015) · European Journal of Neurology · doi:10.1111/ene.12679 · Cited by 38 · see citing works

Full recovery after acute hemorrhagic leukoencephalitis (Hurst's disease)

Klein, C. J., Wijdicks, E. F. M., & Earnest, F. (2000) · Journal of Neurology · doi:10.1007/s004150070060 · Cited by 38 · see citing works

Tumefactive demyelination: clinical, imaging and follow-up observations in thirty-nine patients

Nagappa, M., Taly, A. B., Sinha, S., Bharath, R. D., Mahadevan, A., Bindu, P. S., Saini, J. S., Prasad, C., & Shankar, S. K. (2012) · Acta Neurologica Scandinavica · doi:10.1111/ane.12071 · Cited by 37 · see citing works

Spinal cord involvement in Balo's concentric sclerosis

Kreft, K. L., Mellema, S., & Hintzen, R. Q. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.12.030 · Cited by 35 · see citing works

Early and widespread injury of astrocytes in the absence of demyelination in acute haemorrhagic leukoencephalitis

Robinson, C. A., Adiele, R. C., Tham, M., Lucchinetti, C. F., & Popescu, B. F. G. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-52 · Cited by 34 · see citing works

Isolated tumefactive demyelinating lesions: diagnosis and long-term evolution of 16 patients in a multicentric study

Siri, A., Dalliere, C. C., Ayrignac, X., Pelletier, J., Audoin, B., Pittion‐Vouyovitch, S., Debouverie, M., Lionnet, C., Viala, F., Sablot, D., et al. (2015) · Journal of Neurology · doi:10.1007/s00415-015-7758-8 · Cited by 34 · see citing works

CADASIL mutation and Balo concentric sclerosis: A link between demyelination and ischemia?

Chitnis, T., & Hollmann, T. J. (2012) · Neurology · doi:10.1212/wnl.0b013e31823fcd3c · Cited by 33 · see citing works

Acute Tumefactive Demyelinating Lesions in a Pediatric Patient With Known Diagnosis of Multiple Sclerosis: Review of the Literature and Treatment Proposal

Dastgir, J., & DiMario, F. J. (2009) · Journal of Child Neurology · doi:10.1177/0883073808324769 · Cited by 33 · see citing works

An Autopsy Case of the Marburg Variant of Multiple Sclerosis (Acute Multiple Sclerosis)

Suzuki, M., Kawasaki, H., Masaki, K., Suzuki, S. O., Terada, T., Tsuchida, T., Tokuyama, T., Kono, S., Komori, T., Baba, S., et al. (2013) · Internal Medicine · doi:10.2169/internalmedicine.52.0425 · Cited by 32 · see citing works

A Long-Term Follow-Up Study Using IPMSSG Criteria in Children With CNS Demyelination

Peche, S. S., Alshekhlee, A., Kelly, J., Lenox, J., & Mar, S. (2013) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2013.06.023 · Cited by 32 · see citing works

Anti-Aquaporin-4 Antibody-Seronegative NMO Spectrum Disorder with Baló's Concentric Lesions

Masuda, H., Mori, M., Katayama, K., Kikkawa, Y., & Kuwabara, S. (2013) · Internal Medicine · doi:10.2169/internalmedicine.52.9330 · Cited by 27 · see citing works

Baló's concentric sclerosis and tumefactive demyelination: A shared immunopathogenesis?

Hardy, T. A., Beadnall, H. N., Sutton, I. J., Mohamed, A., Jonker, B., Buckland, M. E., & Barnett, M. H. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.11.024 · Cited by 23 · see citing works

Fulminant tumefactive multiple sclerosis: Therapeutic implications of histopathology

Haupts, M. R., Schimrigk, S., Brune, N., Chan, A., Ahle, G., Hellwig, K., König, F. B., Schlegel, U. S., Brück, W., & Gold, R. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0883-x · Cited by 22 · see citing works

An Autopsy Case of Schilder’s Variant of Multiple Sclerosis (Schilder’s Disease)

Miyamoto, N., Kagohashi, M., Nishioka, K., Fujishima, K., Kitada, T., Tomita, Y., Mori, K., Maëda, M., Wada, R., Matsumoto, M., et al. (2006) · European Neurology · doi:10.1159/000092785 · Cited by 21 · see citing works

Rituximab for tumefactive inflammatory demyelination: A case report

Fan, X., Mahta, A., Jager, P. L. D., & Kesari, S. (2012) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2012.03.010 · Cited by 20 · see citing works

Tumefactive multiple sclerosis requiring emergency craniotomy: Case report and literature review

Munarriz, P. M., Castaño-León, A. M., Martínez-Pérez, R., Hernández‐Laín, A., Ramos, A., & Lagares, A. (2013) · Neurocirugía · doi:10.1016/j.neucir.2013.02.008 · Cited by 15 · see citing works

Tumefactive demyelinating lesions: Characteristics of individual lesions, individual patients, or a unique disease entity?

Weinshenker, B. G. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515603801 · Cited by 14 · see citing works

Concentric Sclerosis (Baló's Disease)

Tabira, T. (2009) · doi:10.1002/9781444317008.ch105 · Cited by 5 · see citing works

0842 Myelin-oligodendrocyte glycoprotein antibody as a cause of acute disseminated encephalomyelitis with a neuromyelitis optica-like phenotype in adults

Kitley, J., Woodhall, M. R., Waters, P. J., Leite, M. I., Devenney, E. M., Craig, J. E., Vincent, A. C., & Palace, J. A. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301993.34 · Cited by 3 · see citing works

Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis

Ramanathan, S., Reddel, S., Henderson, A. P. D., Parratt, J. D. E., Barnett, M. H., Gatt, P. N., Merheb, V., Kumaran, R.-Y. A., Pathmanandavel, K., Sinmaz, N., et al. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.08.065 · Cited by 3 · see citing works

Myelin in the Central Nervous System: Structure, Function, and Pathology

Stadelmann, C., Timmler, S., Barrantes‐Freer, A., & Simons, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00031.2018 · Cited by 735 · see citing works

Diagnosis of multiple sclerosis: progress and challenges

Brownlee, W. J., Hardy, T. A., Fazekas, F., & Miller, D. H. (2017) · The Lancet · doi:10.1016/s0140-6736(16)30959-x · Cited by 701 · see citing works

Myelin oligodendrocyte glycoprotein antibodies in neurological disease

Reindl, M., & Waters, P. J. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0112-x · Cited by 627 · see citing works

Microglia in multiple sclerosis: Friend or foe

Guerrero, B. L., & Sicotte, N. L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00374 · Cited by 215 · see citing works

Myelin oligodendrocyte glycoprotein antibodies: How clinically useful are they?

Reindl, M., Jarius, S., Rostasy, K. M., & Berger, T. (2017) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000446 · Cited by 100 · see citing works

Neuroinflammation in Parkinson’s Disease – Putative Pathomechanisms and Targets for Disease-Modification

Grotemeyer, A., McFleder, R. L., Wu, J., Wischhusen, J., & Ip, C. W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.878771 · Cited by 91 · see citing works

A Review of Clinical and Imaging Findings in Tumefactive Demyelination

Nakayama, M., Naganawa, S., Ouyang, M., Jones, K. A., Kim, J., Capizzano, A. A., & Moritani, T. (2021) · American Journal of Roentgenology · doi:10.2214/ajr.20.23226 · Cited by 82 · see citing works

Tolerance checkpoint bypass permits emergence of pathogenic T cells to neuromyelitis optica autoantigen aquaporin-4

Sagan, S. A., Winger, R. C., Cruz-Herranz, A., Nelson, P. A., Hagberg, S., Miller, C. N., Spencer, C. M., Ho, P. P.-K., Bennett, J. L., Levy, M., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617859114 · Cited by 80 · see citing works

Immunogenicity and predictors of response to a single dose trivalent seasonal influenza vaccine in multiple sclerosis patients receiving disease‐modifying therapies

Metze, C., Winkelmann, A., Loebermann, M., Hecker, M., Schweiger, B., Reisinger, E. C., & Zettl, U. K. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13034 · Cited by 79 · see citing works

Diagnosis of multiple sclerosis: revisions of the McDonald criteria 2017 – continuity and change

Hartung, H., Graf, J., Aktaş, O., Mareš, J., & Barnett, M. H. (2019) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000699 · Cited by 62 · see citing works

Immunopathogenesis in Myasthenia Gravis and Neuromyelitis Optica

Wang, Z., & Yan, Y. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01785 · Cited by 62 · see citing works

Brazilian Consensus for the Treatment of Multiple Sclerosis: Brazilian Academy of Neurology and Brazilian Committee on Treatment and Research in Multiple Sclerosis

Marques, V. D., dos Passos, G. R., Mendes, M. F., Callegaro, D., Lana–Peixoto, M. A., Comini-Frota, E. R., Vasconcelos, C. C. F., Sato, D. K., Ferreira, M. L. B., Parolin, M. K. F., et al. (2018) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x20180078 · Cited by 62 · see citing works

Pseudotumoral demyelinating lesions: diagnostic approach and long-term outcome

Hardy, T. A. (2019) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000683 · Cited by 52 · see citing works

Encapsulation of bryostatin-1 by targeted exosomes enhances remyelination and neuroprotection effects in the cuprizone-induced demyelinating animal model of multiple sclerosis

Wu, X., Liao, B.-Y., Xiao, D., Wu, W., Xiao, Y., Alexander, T. D., Song, S., Zhao, Z.-H., Zhang, Y., Wang, Z., et al. (2021) · Biomaterials Science · doi:10.1039/d1bm01142a · Cited by 51 · see citing works

Pathogenic autoantibodies in multiple sclerosis — from a simple idea to a complex concept

Höftberger, R., Lassmann, H., Berger, T., & Reindl, M. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00700-2 · Cited by 50 · see citing works

Tumefactive demyelinating lesions of 15 patients: Clinico-radiological features, management and review of the literature.

Sánchez, P., Meca‐Lallana, V., Barbosa, A., Manzanares, R., Palmí, I., & Vivancos, J. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.08.005 · Cited by 49 · see citing works

Clinical and Radiologic Features, Pathology, and Treatment of Baló Concentric Sclerosis

Jolliffe, E. A., Guo, Y., Hardy, T. A., Morris, P. P., Flanagan, E. P., Lucchinetti, C. F., & Tobin, W. O. (2021) · Neurology · doi:10.1212/wnl.0000000000012230 · Cited by 45 · see citing works

Common Clinical and Imaging Conditions Misdiagnosed as Multiple Sclerosis

Sıva, A. (2017) · Neurologic Clinics · doi:10.1016/j.ncl.2017.08.014 · Cited by 43 · see citing works

Understanding Childhood Neuroimmune Diseases of the Central Nervous System

Matricardi, S., Farello, G., Savasta, S., & Verrotti, A. (2019) · Frontiers in Pediatrics · doi:10.3389/fped.2019.00511 · Cited by 40 · see citing works

Spinal Cord Anatomy and Localization

Hardy, T. A. (2021) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000899 · Cited by 37 · see citing works

The spectrum of immune-mediated and inflammatory lesions of the brainstem

Law, L. Y., Riminton, S., Nguyen, M., Barnett, M. H., Reddel, S., & Hardy, T. A. (2019) · Neurology · doi:10.1212/wnl.0000000000008015 · Cited by 34 · see citing works

Experimental Models of Autoimmune Demyelinating Diseases in Nonhuman Primates

Stimmer, L., Fovet, C.-M., & Serguera, C. (2017) · Veterinary Pathology · doi:10.1177/0300985817712794 · Cited by 32 · see citing works

The Pathological Activation of Microglia Is Modulated by Sexually Dimorphic Pathways

O'Connor, J. L., & Nissen, J. C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054739 · Cited by 31 · see citing works

Defining the natural history of tumefactive demyelination: A retrospective cohort of 257 patients

Fereidan‐Esfahani, M., Decker, P. A., Weigand, S. D., Lopez-Chiriboga, A. S., Flanagan, E. P., Tillema, J., Lucchinetti, C. F., Eckel‐Passow, J. E., & Tobin, W. O. (2023) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51844 · Cited by 30 · see citing works

Diagnose der Multiplen Sklerose: Revision der McDonald-Kriterien 2017

Aktaş, O., Wattjes, M. P., Stangel, M., & Hartung, H. (2018) · Der Nervenarzt · doi:10.1007/s00115-018-0550-0 · Cited by 18 · see citing works

Tumefactive demyelination: updated perspectives on diagnosis and management

Sánchez, P., Chan, F., & Hardy, T. A. (2021) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2021.1971077 · Cited by 27 · see citing works

Population‐based incidence and clinico‐radiological characteristics of tumefactive demyelination in Olmsted County, Minnesota, United States

Fereidan‐Esfahani, M., Decker, P. A., Passow, J. E. E., Lucchinetti, C. F., Flanagan, E. P., & Tobin, W. O. (2021) · European Journal of Neurology · doi:10.1111/ene.15182 · Cited by 27 · see citing works

Automated histologic diagnosis of CNS tumors with machine learning

Khalsa, S. S. S., Hollon, T. C., Adapa, A. R., Urias, E., Srinivasan, S., Jairath, N. K., Szczepanski, J. M., Ouillette, P. D., Camelo-Piragua, S. I., & Orringer, D. A. (2020) · CNS Oncology · doi:10.2217/cns-2020-0003 · Cited by 26 · see citing works

Cyclophosphamide in treatment of tumefactive multiple sclerosis

Fereidan-Esfahani, M., & Tobin, W. O. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102627 · Cited by 26 · see citing works

Atypical inflammatory demyelinating lesions and atypical multiple sclerosis

Ayrignac, X., Dalliere, C. C., & Labauge, P. M. (2018) · Revue Neurologique · doi:10.1016/j.neurol.2018.03.007 · Cited by 25 · see citing works

Update on pathology of central nervous system inflammatory demyelinating diseases

Kalinowska, A., Guo, Y., & Lucchinetti, C. F. (2022) · Neurologia i Neurochirurgia Polska · doi:10.5603/pjnns.a2022.0046 · Cited by 28 · see citing works

Adult-Onset Genetic Central Nervous System Disorders Masquerading as Acquired Neuroinflammatory Disorders

Ayrignac, X., Dalliere, C. C., Marelli, C., Taïeb, G., & Labauge, P. M. (2022) · JAMA Neurology · doi:10.1001/jamaneurol.2022.2141 · Cited by 25 · see citing works

Post-malaria neurological syndrome: four cases, review of the literature and clarification of the nosological framework

Tamzali, Y., Demeret, S., Haddad, É., Guillot, H., Caumes, É., & Jauréguiberry, S. (2018) · Malaria Journal · doi:10.1186/s12936-018-2542-8 · Cited by 25 · see citing works

Clinico-radiologic features and therapeutic strategies in tumefactive demyelination: a retrospective analysis of 50 consecutive cases

Vakrakou, A. G., Tzanetakos, D., Evangelopoulos, M., Argyrakos, T., Tzartos, J. S., Anagnostouli, M. C., Andreadou, E., Koutsis, G., Velonakis, G., Toulas, P., et al. (2021) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864211006503 · Cited by 24 · see citing works

Acute Hemorrhagic Leukoencephalitis (AHLE): A Comprehensive Review on Causes, Symptoms, Link with COVID‐19, Diagnosis, and Treatment

Alromaihi, M. (2022) · BioMed Research International · doi:10.1155/2022/6008375 · Cited by 25 · see citing works

Retinal vasculopathy with cerebral leukoencephalopathy (RVCL)

Raynowska, J., Miskin, D. P., Pramanik, B. K., Asiry, S., Anderson, T. A., Boockvar, J. A., Najjar, S., & Harel, A. (2018) · Neurology · doi:10.1212/wnl.0000000000006329 · Cited by 24 · see citing works

Heterogeneity of Baló’s concentric sclerosis: a study of eight cases with different therapeutic concepts

Tzanetakos, D., Vakrakou, A. G., Tzartos, J. S., Velonakis, G., Evangelopoulos, M., Anagnostouli, M. C., Koutsis, G., Dardiotis, E., Karavasilis, E., Toulas, P., et al. (2020) · BMC Neurology · doi:10.1186/s12883-020-01971-2 · Cited by 22 · see citing works

Recurrent Fulminant Tumefactive Demyelination With Marburg-Like Features and Atypical Presentation: Therapeutic Dilemmas and Review of Literature

Vakrakou, A. G., Tzanetakos, D., Argyrakos, T., Koutsis, G., Evangelopoulos, M., Andreadou, E., Anagnostouli, M. C., Breza, M., Tzartos, J. S., GIALAFOS, E. J., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00536 · Cited by 22 · see citing works

Autoimmune Brainstem Encephalitis: An Illustrative Case and a Review of the Literature

Zoghaib, R., Sreij, A., Maalouf, N., Freiha, J., Kikano, R., Riachi, N. J., Chalah, M. A., Ayache, S. S., & Ahdab, R. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10132970 · Cited by 20 · see citing works

7 Tesla MRI of Balo's concentric sclerosis versus multiple sclerosis lesions

Behrens, J. R., Wanner, J., Kuchling, J., Ostendorf, L., Harms, L., Ruprecht, K., Niendorf, T., Jarius, S., Wildemann, B., Gieß, R. M., et al. (2018) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.572 · Cited by 20 · see citing works

Tumor-like Lesions in Primary Angiitis of the Central Nervous System: The Role of Magnetic Resonance Imaging in Differential Diagnosis

Zedde, M., Napoli, M., Moratti, C., Pavone, C., Bonacini, L., Cecco, G. D., D’Aniello, S., Grisendi, I., Assenza, F., Boulouis, G., et al. (2024) · Diagnostics · doi:10.3390/diagnostics14060618 · Cited by 18 · see citing works

Diagnostic approach in multiple sclerosis with MRI: an update

Weidauer, S., Raab, P., & Hattingen, E. (2021) · Clinical Imaging · doi:10.1016/j.clinimag.2021.05.025 · Cited by 18 · see citing works

Multiple sclerosis with atypical MRI presentation: Results of a nationwide multicenter study in 57 consecutive cases

Codjia, P., Ayrignac, X., Dalliere, C. C., Cohen, M., Charif, M., Lippi, A., Collongues, N., Corti, L., Seze, J. D., Lebrun‐Frénay, C., et al. (2018) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.12.022 · Cited by 18 · see citing works

Differential imaging of atypical demyelinating lesions of the central nervous system

Paoletti, M., Muzic, S. I., Marchetti, F., Farina, L. M., Bastianello, S., & Pichiecchio, A. (2021) · La radiologia medica · doi:10.1007/s11547-021-01334-y · Cited by 17 · see citing works

Baló concentric sclerosis evolving from apparent tumefactive demyelination

Hardy, T. A., Corboy, J. R., & Weinshenker, B. G. (2017) · Neurology · doi:10.1212/wnl.0000000000003990 · Cited by 17 · see citing works

Clinical and radiological characteristics and outcomes of patients with recurrent or relapsing tumefactive demyelination

Pervin, I., Ramanathan, S., Cappelen‐Smith, C., Vucic, S., Reddel, S., & Hardy, T. A. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.105408 · Cited by 15 · see citing works

Investigation of tumefactive demyelination is associated with higher economic burden and more adverse events compared with conventional multiple sclerosis

Silsby, M., Sánchez, P., Spies, J. M., Frith, J., Barton, J., Beadnall, H. N., Barnett, M. H., Reddel, S., & Hardy, T. A. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2019.07.013 · Cited by 15 · see citing works

Multiple Sclerosis: Shall We Target CD33?

Siokas, V., Tsouris, Z., Aloizou, A., Bakirtzis, C., Liampas, I., Koutsis, G., Anagnostouli, M. C., Bogdanos, D. P., Grigoriadis, N., Hadjigeorgiou, G. M., et al. (2020) · Genes · doi:10.3390/genes11111334 · Cited by 15 · see citing works

Correlation between Amerindian ancestry and neuromyelitis optica spectrum disorders (NMSOD) among patients in Midwestern Brazil

Alves, C. S., Santos, F. B. C., & Diniz, D. S. (2022) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x-anp-2020-0527 · Cited by 14 · see citing works

Pathologic and MRI analysis in acute atypical inflammatory demyelinating lesions

Ayrignac, X., Rigau, V., Lhermitte, B., Vincent, T., de Champfleur, N. M., Dalliere, C. C., Charif, M., Collongues, N., Seze, J. D., Hebbadj, S., et al. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09328-7 · Cited by 14 · see citing works

23 Na MRI reveals persistent sodium accumulation in tumefactive MS lesions

Huhn, K., Mennecke, A., Linz, P. R., Tschunko, F., Kästle, N., Nagel, A. M., Uder, M., Dörfler, A., Linker, R. A., & Engelhorn, T. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.06.003 · Cited by 13 · see citing works

Neuromyelitis optica spectrum disorder: pathophysiological approach

Mireles-Ramírez, M. A., Pacheco-Moisés, F. P., González-Usigli, H., Sánchez-Rosales, N. A., Hernández-Preciado, M. R., Delgado-Lara, D. L. C., Hernández-Cruz, J. J., & Ortíz, G. G. (2022) · International Journal of Neuroscience · doi:10.1080/00207454.2022.2153046 · Cited by 12 · see citing works

Increasing role of imaging in differentiating MS from non-MS and defining indeterminate borderline cases

Juryńczyk, M., Jakuszyk, P., Kurkowska‐Jastrzębska, I., & Palace, J. A. (2021) · Neurologia i Neurochirurgia Polska · doi:10.5603/pjnns.a2021.0077 · Cited by 12 · see citing works

Imaging of Fulminant Demyelinating Disorders of the Central Nervous System

Razek, A. A. K. A., & Elsebaie, N. A. (2020) · Journal of Computer Assisted Tomography · doi:10.1097/rct.0000000000000997 · Cited by 11 · see citing works

How should we diagnose acute disseminated encephalomyelitis?

Hardy, T. A. (2018) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.13940 · Cited by 10 · see citing works

Are highly active and aggressive multiple sclerosis the same entity?

Correale, J. D., Rush, C., & Barboza, A. G. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1132170 · Cited by 10 · see citing works

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Sagan, S. A., Cruz-Herranz, A., Spencer, C. M., Ho, P. P.-K., Steinman, L., Green, A., Sobel, R. A., & Zamvil, S. S. (2017) · Journal of Visualized Experiments · doi:10.3791/56185 · Cited by 10 · see citing works

Distinguishing CNS neurosarcoidosis from multiple sclerosis and an approach to “overlap” cases

Chan, F., Riminton, S., Ramanathan, S., Reddel, S., & Hardy, T. A. (2022) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2022.577904 · Cited by 10 · see citing works

Diagnosis and Management of Central Nervous System Demyelinating Disorders

Touma, L., & Muccilli, A. D. (2021) · Neurologic Clinics · doi:10.1016/j.ncl.2021.08.008 · Cited by 9 · see citing works

From Baló’s concentric sclerosis to multiple sclerosis: a series of 6 patients

Ayrignac, X., Guillon, L. L., Dalliere, C. C., Duquette, P., Girard, M., Poirier, J. B., Lahav, B., Larochelle, C., & Prat, A. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102078 · Cited by 9 · see citing works

Pure Relapsing Short Myelitis

Poullet, Z., Pique, J., Maarouf, A., Boutière, C., Rico, A., Demortière, S., Durozard, P., Papeix, C., Maillart, É., Collongues, N., et al. (2022) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000001167 · Cited by 8 · see citing works

Acute hemorrhagic leukoencephalitis as a new phenotype of myelin oligodendrocyte glycoprotein antibody-associated disease

Bang, S. J., Kim, S., & Seok, H. Y. (2023) · Neurological Sciences · doi:10.1007/s10072-023-06847-0 · Cited by 8 · see citing works

Biomarkers in Rare Demyelinating Disease of the Central Nervous System

Boziki, M. K., Sintila, S.-A., Ioannidis, P., & Grigoriadis, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218409 · Cited by 8 · see citing works

Clinical presentation of a neuropsychiatric lupus patient with symmetrical basal ganglia lesions containing cytotoxic oedema cores surrounded by vasogenic oedema

Tsubouchi, S., Hayashi, H., Tahara, K., Ishii, K., Yasuda, T., Yamamoto, Y., Mizuuchi, T., Mori, H., Tago, M., Kato, E., et al. (2019) · Modern Rheumatology Case Reports · doi:10.1080/24725625.2019.1651955 · Cited by 7 · see citing works

Case report: MOG-IgG-associated encephalitis with Epstein-Barr virus infection and Alzheimer's pathologic change in cerebrospinal fluid

Li, L., Li, C., Yao, D., Hao, Y., Zhao, C., Yan, Q., Liu, J.-T., Liu, S.-Y., Zhu, W.-P., Du, Y., et al. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.1013413 · Cited by 7 · see citing works

Sera of Neuromyelitis Optica Patients Increase BID-Mediated Apoptosis in Astrocytes

Zveik, O., Rechtman, A., Haham, N., Adini, I., Canello, T., Lavon, I., Brill, L., & Vaknin‐Dembinsky, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137117 · Cited by 7 · see citing works

Pseudotumoral brain lesions: MRI review

Renard, D., Castelnovo, G., Floch, A. L., Guillamo, J., & Thouvenot, É. (2016) · Acta Neurologica Belgica · doi:10.1007/s13760-016-0725-z · Cited by 7 · see citing works

Silent Tumefactive Demyelinating Lesions and Radiologically Isolated Syndrome

Ekmekçi, Ö., & Eraslan, C. (2018) · Case Reports in Neurological Medicine · doi:10.1155/2018/8409247 · Cited by 7 · see citing works

Consensus recommendation on the use of therapeutic plasma exchange for adult neurological diseases in Southeast Asia from the Southeast Asia therapeutic plasma exchange consortium

Hiew, F. L., Thit, W. M., Alexander, M., Thirugnanam, U. N., Siritho, S., Tan, K., Aye, S. M. M., Ohnmar, O., Estiasari, R., Yassin, N., et al. (2021) · Journal of Central Nervous System Disease · doi:10.1177/11795735211057314 · Cited by 6 · see citing works

Pediatric multiple sclerosis and fulminant disease course: Features and approaches to treatment – A case report and review of the literature

Sandi, D., Bereg, E., Biernacki, T., Vörös, E., Klivènyi, P., Bereczki, C., Vécsei, L., & Bencsik, K. (2018) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2018.04.053 · Cited by 6 · see citing works

Cyclophosphamide in highly aggressive Marburg-like multiple sclerosis

Nicoletti, T. F., Bianco, A. D., Lucchini, M., Gaudino, S., Frisullo, G., & Massimiliano Mirabella, A. (2021) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864211050028 · Cited by 6 · see citing works

The clinical spectrum of haemorrhagic CNS inflammatory demyelinating lesions

Hardy, T. A., Guo, Y., Flanagan, E. P., Lucchinetti, C. F., & Tobin, W. O. (2022) · Multiple Sclerosis Journal · doi:10.1177/13524585221094241 · Cited by 6 · see citing works

Exogenous Antioxidants in Remyelination and Skeletal Muscle Recovery

Cabezas-Pérez, R., Ávila-Rodriguez, M., & Salazar, D. H. R. (2022) · Biomedicines · doi:10.3390/biomedicines10102557 · Cited by 6 · see citing works

Overview of Mechanisms Underlying Neuroimmune Diseases

Sonar, S. A., & Lal, G. (2019) · Contemporary clinical neuroscience · doi:10.1007/978-3-030-19515-1_1 · Cited by 5 · see citing works

Patterns of autoantibody expression in multiple sclerosis identified through development of an autoantigen discovery technology

DiCillo, E. B., Kountikov, E. I., Zhu, M., Lanker, S., Harlow, D. E., Piette, E. R., Zhang, W., Hayward, B., Heuler, J., Korich, J., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci171948 · Cited by 5 · see citing works

Progression of tumefactive demyelinating lesion in a child demonstrated with MRI

Simone, M. D., Brogna, B., Spitaleri, D. L. A., Cicarelli, G., Fantozzi, R., & Guida, B. (2017) · Radiology Case Reports · doi:10.1016/j.radcr.2017.10.026 · Cited by 5 · see citing works

Long-term remission of tumefactive relapsing multiple sclerosis after alemtuzumab rescue treatment in an adolescent patient

Baroncini, D., Annovazzi, P. O. L., Guaschino, C., Minonzio, G., Hametner, S., Stadelmann, C., Comi, G. P., Ghezzi, A., & Zaffaroni, M. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102061 · Cited by 5 · see citing works

Balo's concentric lesions with concurrent features of Schilder s disease in relapsing multiple sclerosis: neuropathological findings

Kurdi, M. E., & Ramsay, D. A. (2016) · Autopsy and Case Reports · doi:10.4322/acr.2016.058 · Cited by 5 · see citing works

Diagnostic and therapeutic issues of inflammatory diseases of the elderly

Ayrignac, X., Dalliere, C. C., & Labauge, P. M. (2020) · Revue Neurologique · doi:10.1016/j.neurol.2020.03.014 · Cited by 5 · see citing works

Hybrid 18F-florbetapir PET/MRI for assessing myelin recovery in GFAP-A patients

Meng, H., Zheng, S., Yuan, S., Zhou, Q., Gao, Y., Ni, Y., He, L., Yin, D., Zhang, M., & Chen, S. (2022) · Translational Neuroscience · doi:10.1515/tnsci-2022-0223 · Cited by 5 · see citing works

Prolonged Codeine Administration Causes Degeneration of Myelinated Axons and Motor Dysfunction in Wistar Rats

Archibong, V. B., Usman, I. M., & Lemuel, A. M. (2022) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s365982 · Cited by 5 · see citing works

Aquaporin-4-IgG-positive neuromyelitis optica spectrum disorder with recurrent short partial transverse myelitis and favorable prognosis: Two new cases

Zhang, J., Liu, F., Wang, Y., Yang, Y., Huang, Y., Zhao, H., Bi, Y., Shi, T., Guo, S., & Wang, M. (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458517705479 · Cited by 5 · see citing works

The latest diagnostic criteria and treatment options for neuromyelitis optica

Moore, R. R., & Tanner, M. (2019) · JAAPA · doi:10.1097/01.jaa.0000558352.01234.c0 · Cited by 5 · see citing works

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Sagan, S. A., Cruz-Herranz, A., Spencer, C. M., Ho, P. P.-K., Steinman, L., Green, A., Sobel, R. A., & Zamvil, S. S. (2017) · Journal of Visualized Experiments · doi:10.3791/56185-v · Cited by 5 · see citing works

Etiology and characteristics of pseudotumoral lesions and tumefactive demyelination in multiple sclerosis

Tamaš, O., Kovačević, M., Veselinovic, N., Budimkic, M. S., Jovičević, V., Momčilović, N., Drulovic, J. S., & Mesaroš, Š. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.106168 · Cited by 4 · see citing works

Case Report: Baló's Concentric Sclerosis-Like Lesion in a Patient With Relapsing-Remitting Multiple Sclerosis Treated With Dimethyl Fumarate

Kania, K., Ambrosius, W., Kozubski, W. P., & Kalinowska, A. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.891113 · Cited by 4 · see citing works

Mystery Case: A case of fulminant encephalopathy in a 69-year-old woman

Lamotte, G. J., & Williams, C. (2017) · Neurology · doi:10.1212/wnl.0000000000004288 · Cited by 4 · see citing works

Fulminant inflammatory demyelination presenting as stroke‐in‐evolution in an elderly subject

Sacco, S., Callegari, I., Canavero, I., Coloberti, E., Farina, L. M., Ravaglia, S., Simoncelli, A. M., Pichiecchio, A., & Micieli, G. (2020) · Brain and Behavior · doi:10.1002/brb3.1967 · Cited by 4 · see citing works

Misinterpretation of glioblastoma as ADEM: potentially harmful consequences of over-diagnosis of COVID-19 vaccine-associated adverse events

O´Sullivan, C., Zach, F., Moser, T., Pilz, G., Harrer, A., Trinka, E., Enzinger, C., Pfaff, J. A. R., & Wipfler, P. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10707-2 · Cited by 4 · see citing works

Clinical characteristics of double negative atypical inflammatory demyelinating disease: A prospective study

Jiang, F., Cai, H., Li, H., Yin, W., Ouyang, S., Hu, J., Tu, E., Fu, K., Yin, J., Zhao, Z. W., et al. (2024) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.52191 · Cited by 3 · see citing works

A 42-Year-Old Woman With Rapidly Expanding White Matter Lesions

Amiola, T. O., Oh, U., Richard, H., Newsome, S. D., Graves, J. S., Zamvil, S. S., & Goldman, M. D. (2024) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200201 · Cited by 3 · see citing works

Panencephalitis in children in modern conditions: clinical, etiological and mri-aspects

Скрипченко, Н. В., Ivanova, G. P., Skripchenko, E. Y., & Александровна, М. Е. (2019) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro201911906120 · Cited by 3 · see citing works

Baló concentric sclerosis: Literature review and report of two cases

Fonseca, A., Santos, E., & Taipa, R. J. F. (2024) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2024.578370 · Cited by 2 · see citing works

Acute haemorrhagic necrotizing encephalopathy and inflammatory demyelinating encephalopathy associated with COVID-19 in adults in Southern China

Tan, S., Cui, C., Song, E., Shan, Y., Chang, Y., Qiu, W., & Lu, Z. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-11404-5 · Cited by 2 · see citing works

Co-existing of Neuromyelitis Optica and Fulminant Type 1 Diabetes

Saheki, T., Imachi, H., Ibata, T., Fukunaga, K., Yoshioka, Y., Kobayashi, T., Sato, S., Mizumoto, K., Yoshimoto, T., Lyu, J., et al. (2019) · Internal Medicine · doi:10.2169/internalmedicine.2353-18 · Cited by 2 · see citing works

Tumefactive multiple sclerosis

Tosunoğlu, B., Çokal, B. G., Güneş, H. N., Kaya, N., & Yoldaş, T. K. (2024) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2023.2289301 · Cited by 2 · see citing works

Fingolimod‐associated Balo's concentric sclerosis in multiple sclerosis: A case report

Sharifi, P., Moradi, A., & Moghadasi, A. N. (2024) · Clinical Case Reports · doi:10.1002/ccr3.9266 · Cited by 2 · see citing works

Long-term Outcome of Schilder Disease Treated With Interferon-β

Lin, W., Kuo, M., Peng, S. S., & Fan, P. (2019) · PEDIATRICS · doi:10.1542/peds.2019-0505 · Cited by 2 · see citing works

Acute Disseminated Encephalomyelitis and Acute Hemorrhagic Leukoencephalomyelitis

Höftberger, R., & Lassmann, H. (2020) · doi:10.1002/9781119467748.ch26 · Cited by 2 · see citing works

Pseudocystic demyelination in multiple sclerosis

Hardy, T. A. (2023) · Multiple Sclerosis Journal · doi:10.1177/13524585231193365 · Cited by 2 · see citing works

The Spectrum of Atypical Inflammatory Demyelinating Syndromes of the Central Nervous System

Hardy, T. A. (2024) · Springer eBooks · doi:10.1007/978-3-031-60006-7_17

Atypical Inflammatory Demyelinating Syndromes of the Central Nervous System

Hardy, T. A. (2019) · Contemporary clinical neuroscience · doi:10.1007/978-3-030-19515-1_17 · Cited by 1 · see citing works

Atypical inflammatory demyelinating lesions and atypical multiple sclerosis

Ayrignac, X., Dalliere, C. C., & Labauge, P. M. (2018) · Revue Neurologique · doi:10.1016/j.neurol.2018.03.007 · Cited by 25 · see citing works

The Spectrum of Demyelinating Inflammatory Diseases of the Central Nervous System

Brochet, B. (2015) · Neuropsychiatric symptoms of neurological disease · doi:10.1007/978-3-319-18464-7_1 · Cited by 1 · see citing works

Advances in Diagnosis and Management of Atypical Demyelinating Diseases

Hutto, S. K., & Cavanagh, J. J. (2024) · Medical Clinics of North America · doi:10.1016/j.mcna.2024.09.011 · Cited by 4 · see citing works